Phase 2 Study to Evaluate PVX-410 + Pembrolizumab + Chemotherapy for Metastatic, PD-L1+ Triple-Negative Breast Cancer

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.